Sleep Health

Sleep Apnea in Pregnancy Gets National Attention

During a casual conversation at a Texas Medical Association (TMA) event, Dr. Vani Vallabhaneni, a sleep and internal medicine physician, posed a question that would ultimately trigger a major shift in national medical policy. When she asked an obstetrician-gynecologist how they managed sleep apnea in pregnant patients, the response was jarring: the OB/GYN noted that while they would provide oxygen if a patient became hypoxic during labor, they did not proactively screen for or investigate sleep-disordered breathing during the pregnancy itself.

For Dr. Vallabhaneni, the medical director at Sleep 360 Sleep Diagnostic Center in Austin and a clinical assistant professor at Texas A&M University, this revelation highlighted a dangerous oversight in modern obstetric care. The realization that pregnant women could be experiencing chronic, recurrent hypoxemia without clinical intervention prompted Dr. Vallabhaneni to launch a multi-year advocacy mission. This effort culminated in June 2026, when the American Medical Association (AMA) officially adopted a landmark policy recognizing the risks of obstructive sleep apnea (OSA) during pregnancy, marking a turning point in how the medical community approaches maternal health.

A Gap in Maternal Healthcare

The journey toward policy change began in 2024 at the TMA’s TexMed Conference in Dallas. During a meeting of the Women Physician Section, Dr. Vallabhaneni analyzed the state’s worsening maternal mortality crisis. While maternal mortality is inherently multifactorial, she sought to identify modifiable risk factors that had been historically overlooked. Her research confirmed a significant gap: there was no formal guidance on how to identify or treat OSA in pregnant patients, despite its strong correlation with serious complications like pregnancy-induced hypertension, preeclampsia, and gestational diabetes.

The data supporting the need for this policy is substantial. Studies indicate that OSA affects between 5% and 20% of pregnant women, a figure that is likely rising alongside increasing obesity rates among women of childbearing age. Furthermore, in April 2025, a report published in JAMA revealed that the age-standardized annual US pregnancy-related mortality rate had climbed by 27.7% between 2018 and 2022, with cardiovascular disease identified as the leading cause of death. By connecting these statistics to the physiological impact of untreated sleep apnea—specifically the intermittent hypoxemia and sympathetic nervous system activation it induces—Dr. Vallabhaneni argued that the medical establishment could no longer treat pregnancy-related sleep disturbances as merely "normal" or "temporary" discomforts.

Sleep Apnea in Pregnancy Gets National Attention

From State Resolution to National Mandate

Dr. Vallabhaneni’s advocacy strategy was systematic. She drafted Texas Medical Association Resolution 311, which she presented to the Council for Science and Public Health at the 2025 TexMed conference. Her presentation focused on debunking the myth that temporary physiological changes in pregnancy equate to benign conditions. She also worked to modernize the perception of sleep medicine among her peers, emphasizing that home sleep testing (HST), APAP therapy, and telemedicine have made diagnosing and treating OSA during pregnancy more accessible and less invasive than traditional in-lab methods.

The resolution passed the TMA in April 2025 without dissent. Dr. Bradford Holland, president of the TMA, lauded the decision, noting that it forced the association to confront a critical clinical blind spot. The success in Texas provided the necessary momentum to take the issue to the national level. By June 2026, the AMA House of Delegates adopted Policy H-440.785, which explicitly addresses OSA during pregnancy. This policy mandates physician education, encourages ongoing research into maternal sleep health, and advocates for insurance coverage to ensure patients have access to life-saving screenings and treatments.

Scientific Evidence and Clinical Pathways

The push for this policy is supported by a growing body of clinical evidence. While association does not always equal causation, recent trials have provided compelling data. A 2023 multicenter randomized controlled trial of 340 high-risk pregnant women showed that CPAP treatment was associated with a 2.2 mmHg reduction in diastolic blood pressure and a significant decrease in the rate of preeclampsia—dropping from 22.3% in the usual-care group to 13.1% in the CPAP-treated group.

A 2024 meta-analysis further bolstered these findings, showing that CPAP users experienced a 35% reduction in the risk of gestational hypertension and a 30% reduction in preeclampsia risk. Dr. Bilgay Izci Balserak, an associate professor at the University of Illinois College of Nursing, notes that while these results do not suggest that OSA causes every pregnancy complication, they confirm that sleep health is an integral component of maternal wellness that requires a coordinated care pathway.

Implementation and Emerging Therapies

Transitioning from policy to clinical practice is the next significant hurdle. Experts suggest that rather than universal screening, a risk-informed approach is most effective. Because standard screening tools like the STOP-Bang questionnaire are often inaccurate for pregnant women—due to the overlap of symptoms like fatigue and weight gain—clinicians are now being encouraged to focus on specific indicators: habitual snoring, witnessed apneas, and daytime sleepiness that is out of proportion to typical pregnancy fatigue.

Sleep Apnea in Pregnancy Gets National Attention

The American College of Chest Physicians (CHEST) reinforced these efforts in October 2026 by publishing guidelines that recommend screening pregnant patients for sleep-disordered breathing. The guidelines support the use of both at-home diagnostic devices and laboratory-based tests.

Recognizing that CPAP compliance can be difficult due to pregnancy-related nasal congestion and nausea, researchers at the Texas A&M University College of Dentistry are investigating oral appliance therapy (OAT). Pilot studies using the myTAP oral appliance have shown promising results in improving sleep quality and reducing snoring frequency, offering a potential alternative for patients who struggle with mask-based therapies.

The Postpartum Transition and Future Outlook

The responsibility of the physician does not end at delivery. Longitudinal research indicates that many women who develop OSA during pregnancy continue to suffer from the condition months after giving birth. Consequently, the new CHEST guidelines recommend that postpartum individuals who received a diagnosis during pregnancy undergo a formal reassessment to determine if the condition has resolved or if ongoing management is required.

Dr. Vallabhaneni emphasizes that the long-term goal is to integrate these protocols into standard electronic medical record (EMR) workflows, ensuring that screening is an automated process rather than a memory-dependent one. Furthermore, she advocates for better communication between obstetricians, sleep specialists, and obstetric anesthesiologists to ensure that a patient’s OSA status is known during labor and delivery.

The adoption of the AMA policy is more than just a bureaucratic success; it is a fundamental shift in how the medical community views maternal health. By framing sleep health as a vital sign, the industry can better address the cardiovascular risks that plague modern pregnancies. For Dr. Vallabhaneni, the challenge ahead is clear: building an infrastructure where evidence-based sleep care is as routine as prenatal vitamin prescriptions or blood pressure checks. With the legislative framework now in place, the focus shifts to implementation, ensuring that physicians and patients alike have the resources necessary to navigate this critical aspect of reproductive health. As the medical community moves forward, the consensus is that the time for treating pregnancy-related sleep disorders as "temporary" is over, replaced by a commitment to safeguarding both mother and child through proactive intervention.

Related Articles

Back to top button